| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PLAB | Common Stock | Options Exercise | $85,835 | +9,688 | +6.1% | $8.86 | 169,281 | 18 Jan 2022 | Direct | |
| transaction | PLAB | Common Stock | Sale | -$189,594 | -9,688 | -5.7% | $19.57 | 159,593 | 18 Jan 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PLAB | Stock Options (Right to Buy) | Options Exercise | $0 | -9,688 | -100% | $0* | 0 | 18 Jan 2022 | Common Stock | 9,688 | $8.86 | Direct |
| Id | Content |
|---|---|
| F1 | The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Progler. |
| F2 | Net proceeds of sale to fund children's education. |